好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluation of New-Onset Seizures in a Safety-Net Hospital Emergency Department
General Neurology
General Neurology Posters (7:00 AM-5:00 PM)
075

This study aims to identify and optimize the evaluation algorithm in our institution for patients who present to the emergency department (ED) with new-onset seizures (NOS) and evaluate follow-up variables based on seizure etiology post discharge.

Annually, 1 million ED visits in this country are due to seizures, including 150,000 patients with NOS. The 2015 AAN guidelines of NOS management discuss risk of seizure recurrence and AED initiation, but does not discuss steps the ED should take in NOS workup or follow-up. The implementation of such guidelines in ED has not been systemically studied.

Retrospective study collecting data from ED visits on patients who presented at Parkland Hospital in Dallas, TX (a safety-net county facility) with a primary diagnosis of seizure from February 2019-January 2020. Data collected included demographics, prior seizure history, clinical workup, and follow-up. All NOS patient management steps and follow-up are documented as a case-series.

Of 232 eligible patients, 23 presented with NOS. Ten (43.4%) were determined to be provoked seizures as follows: 5 alcohol withdrawal/drug ingestion, 2 electrolyte abnormalities, 1 infection, and 2 DKA. Six (26.1%) had intracranial lesions. The etiology in 7 of 23 (30.4%) NOS cases remained unknown; each of these patients had a negative CT-head, and no other provoking factors were found with lab work/imaging. A total of sixteen patients, including all 7 with unknown etiology and 5 with intracranial lesions, had outpatient Neurology referrals (69.6%), but only 6 attended (26.1% of total NOS). None from the unknown etiology group and 3 from the intracranial lesion group attended.

All NOS patients had appropriate ED evaluation. Neurology referrals were placed for the majority of patients, but attendance at follow-up was poor. Further study is needed to determine barriers for patients in getting a neurology referral and in determinants of poor outpatient clinic attendance.

Authors/Disclosures
Fatima Zuberi, MD, BA
PRESENTER
Fatima Zuberi has nothing to disclose.
Anika Morgado Ms. Morgado has nothing to disclose.
Mark Agostini, MD (U.T. Southwestern Medical Center) Dr. Agostini has nothing to disclose.
Rodrigo Zepeda, MD (University of Texas Southwestern) The institution of Dr. Zepeda has received research support from NIH.
Ghazala Perven, MD (UT Southwestern Medical Center) Dr. Perven has nothing to disclose.
Marisara Dieppa, MD (University of Texas SW Medical School) Dr. Dieppa has nothing to disclose.
Alexander Doyle, MD (University of Texas SW Medical School) Dr. Doyle has nothing to disclose.
Ryan Hays, MD, MBA, FAES, FAAN (UT Southwestern Medical Center) Dr. Hays has nothing to disclose.
Rohit Das, MD, FAAN (VA Portland Healthcare System) Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
J. H. Harvey, DO (UT Southwestern Medical Center) Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Hina N. Dave, MD (Debakey VA hospital) Dr. Dave has nothing to disclose.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN (UT Southwestern Medical Center) Dr. Alick-Lindstrom has nothing to disclose.
No disclosure on file
Kan Ding, MD (UT Southwestern Medical Center) The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.